Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock
RVPHOTCPharmaceutical PreparationsFiscal year ends December 31
$0.45−0.02 (-4.36%)
Close on Oct 19, 2026Market cap $5.94MP/E –Yield –
Reviva Pharmaceuticals ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
No ebitda figures for Reviva Pharmaceuticals
Reviva Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?